Jaineya, Myra .
HRN: 13-33-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
09/11/2022
09/17/2022
IV
80mg
OD
Sepsis Sec To AGE With Severe Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes